Anaphylaxis to Gelofusine® confirmed by in vitro basophil activation test: A case series

Anaesthesia

Volumn 61, Issue 3, 2006, Pages 264-268

  Apostolou, E ^a   Deckert, K ^b   Puy, R ^b   Sandrini, A ^b   de Leon, M P ^a   Douglass, J A ^b   Rolland, J M ^a   O'Hehir, Robyn E ^b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD63 ANTIGEN; GELATIN SUCCINATE; NEUROMUSCULAR BLOCKING AGENT; FIBRINOGEN RECEPTOR; GELATIN; LEUKOCYTE ANTIGEN; LYSOSOMAL PROTEIN GP53; PLASMA SUBSTITUTE; SUCCINIC ACID DERIVATIVE;

ADULT; AGED; ANAMNESIS; ANAPHYLAXIS; ARTICLE; BASOPHIL; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; IN VITRO STUDY; MALE; PERIOPERATIVE PERIOD; PREDICTION; RASH; RELIABILITY; SAFETY; SENSITIVITY AND SPECIFICITY; SKIN TEST; BASOPHIL DEGRANULATION TEST; BLOOD; EVALUATION; IMMUNOLOGY; METHODOLOGY; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANTIGENS, CD; BASOPHIL DEGRANULATION TEST; BASOPHILS; FEMALE; FLOW CYTOMETRY; GELATIN; HUMANS; HYPOTENSION; MALE; MIDDLE AGED; PLASMA SUBSTITUTES; PLATELET MEMBRANE GLYCOPROTEINS; SENSITIVITY AND SPECIFICITY; SKIN TESTS; SUCCINATES;

EID: 33644762021     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2005.04529.x     Document Type: Article

References (14)

1. Isbister J, Fisher M. Adverse effects of plasma volume expanders. Anaesthesia and Intensive Care 1980; 8: 145-51.
2. Jenkins S, Clifton M. Gelofusine allergy-the need for identification. Annals of the Royal College of Surgeons of England 2002; 84: 206-7.
3. Pepys J, Pepys E, Baldo B, Whitwam J. Anaphylactic/anaphylactoid reaction to anaesthetic and associated agents: Skin prick tests in aetiological diagnosis. Anaesthesia 1994; 49: 470-5.
4. Russell W, Fenwick D. Anaphylaxis to Haemaccel and cross reactivity to Gelofusin. Anaesthesia and Intensive Care 2002; 30: 481-3.
5. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; i: 466-9.
6. Pool V, Braun M, Kelso J, et al. US vaccine adverse event reporting system. Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps-rubella vaccine in the United States. EPediatrics 2002: 110: e71.
7. Sakaguchi M, Inouye S. IgE sensitization to gelatin: The probable role of gelatin-containing diphtheria-tetanus-acellular pertussis (DTaP) vaccines. Vaccine 2000; 18: 2055-8.
8. Wahl R, Kleinhans D. IgE-mediated allergic reactions to fruit gums and investigation of cross-reactivity between gelatine and modified gelatine-containing products. Clinical and Experimental Allergy 1989; 19: 77-80.
9. Abuaf N, Rajoely B, Ghazouani E, et al. Validation of a flow cytometric assay detecting in vitro basophil activation for the diagnosis of muscle relaxant allergy. Journal of Allergy and Clinical Immunology 1999; 104: 411-8.
10. Torres J, Padial A, Mayorga C, et al. The diagnostic interpretation of basophil activation test in immediate allergic reactions to betalactams. Clinical and Experimental Allergy 2004; 34: 1768-75.
11. Drew A, Eusebius N, Kenins L, et al. Hypoallergenic variants of the major latex allergen Hev b 6.01 retaining human T lymphocyte reactivity. Journal of Immunology 2004; 173: 5872-9.
12. Sanz M, Sanchez G, Gamboa P, et al. Allergen-induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne. Clinical and Experimental Allergy 2001; 31: 1007-13.
13. Gamboa P, Sanz M, Caballero M, et al. The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome. Clinical and Experimental Allergy 2004; 34: 1448-57.
14. Sudheer P, Hall J, Rea G, Rowbottom A, Williams P. Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c. Anaesthesia 2005; 60: 251-6.